A survey of ABCA1 sequence variation confirms association with dementia

Human Mutation

Volumn 30, Issue 9, 2009, Pages 1348-1354

  Reynolds, Chandra A ^a   Hong, Mun Gwan ^b   Eriksson, Ulrika K ^b   Blennow, Kaj ^c   Bennet, Anna M ^b   Johansson, Boo ^d   Malmberg, Bo ^e   Berg, Stig ^e   Wiklund, Fredrik ^b   Gatz, Margaret ^b,f   Pedersen, Nancy L ^b,f   Prince, Jonathan A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e JÖNKÖPING UNIVERSITY   (Sweden)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

ABCA1; Alzheimer; Amyloid; Dementia; SNP

Indexed keywords

ABC TRANSPORTER A1; AMYLOID BETA PROTEIN; LIPID;

ABCA1 GENE; ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; EFFECT SIZE; EXON; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HUMAN; LIPID TRANSPORT; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; RISK; SWEDEN;

AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CASE-CONTROL STUDIES; DATA COLLECTION; DEMENTIA; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; MALE;

EID: 69549130702     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21076     Document Type: Article

References (52)

1. Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K. 1999. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology 53:1488-1494. (Pubitemid 29491942)
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
3. Beekman M, Posthuma D, Heijmans BT, Lakenberg N, Suchiman HE, Snieder H, de Knijff P, Frants RR, van Ommen GJ, Kluft C, Vogler GP, Slagboom PE, Boomsma DI. 2004. Combined association and linkage analysis applied to the APOE locus. Genet Epidemiol 26:328-337. (Pubitemid 38580384)
4. Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, Poirier J. 1999. Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. Brain Res Mol Brain Res 68:181-185. (Pubitemid 29244006)
5. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. 1995. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26:231-245.
6. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. 1999. The gene encoding ATPbinding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351. (Pubitemid 29369524)
7. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest Jr J, Hayden MR. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345. (Pubitemid 29369523)
8. Carey V, Zeger SL, Diggle P. 1993. Modelling multivariate binary data with alternating logistic regressions. Biometrika 80:517-526.
9. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest Jr J, Kastelein JJ, Hayden MR. 2001. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198-1205. (Pubitemid 32221340)
10. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923. (Pubitemid 23275809)
11. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, Taylor J, Burnett E, Gut I, Farrall M, Lathrop GM, Abecasis GR, Cookson WO. 2007. A genome-wide association study of global gene expression. Nat Genet 39:1202-1207. (Pubitemid 47482680)
12. Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW. 2002. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. J Biol Chem 277:48508-48513. (Pubitemid 35470811)
13. Gatz M, Fratiglioni L, Johansson B, Berg S, Mortimer JA, Reynolds CA, Fiske A, Pedersen NL. 2005. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol Aging 26:439-447. (Pubitemid 40093927)
14. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, Posner SF, Viitanen M, Winblad B, Ahlbom A. 1997. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol SciMed Sci 52:M117-M125. (Pubitemid 27123973)
15. Gatz M, Reynolds C, Nikolic J, Lowe B, Karel M, Pedersen N. 1995. An empirical test of telephone screening to identify potential dementia cases. Int Psychogeriatr 7:429-438. (Pubitemid 26053056)
16. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706. (Pubitemid 21912142)
17. Gold CH, Malmberg B, McClearn GE, Pedersen NL, Berg S. 2002. Gender and health: a study of older unlike-sex twins. J Gerontol B Psychol Sci Soc Sci 57:S168-S176. (Pubitemid 34465256)
18. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL. 2004. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279:41197-41207. (Pubitemid 39287722)
19. Jansson M, Gatz M, Berg S, Johansson B, Malmberg B, McClearn GE, Schalling M, Pedersen NL. 2003. Association between depressed mood in the elderly and a 5-HTR2A gene variant. Am J Med Genet B Neuropsychiatr Genet 120B:79-84. (Pubitemid 37059382)
20. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197. (Pubitemid 351171402)
21. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. 2004. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23:358-367. (Pubitemid 38461517)
22. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci USA 98:5815-5820. (Pubitemid 32435725)
23. Lee PH, Shatkay H. 2008. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36:D820-D824. (Pubitemid 351149829)
24. Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, Grupe A. 2004. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366:268-271. (Pubitemid 39024279)
25. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL. 2002. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 252:184-205.
26. Marchini J, Howie B, Myers S, McVean G, Donnelly P. 2007. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39:906-913. (Pubitemid 47014502)
27. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV, Holmans P, Heward CB, Reiman EM, Stephan D, Hardy J. 2007. A survey of genetic human cortical gene expression. Nat Genet 39:1494-1499. (Pubitemid 350191339)
28. Pedersen NL, Friberg L, Floderus-Myrhed B, McClearn GE, Plomin R. 1984. Swedish early separated twins: identification and characterization. Acta Genet Med Gemellol (Roma) 33:243-250. (Pubitemid 15126091)
29. Pedersen NL, Gatz M, Berg S, Johansson B. 2004. How heritable is Alzheimer's disease late in life? Findings from Swedish twins. Ann Neurol 55:180-185. (Pubitemid 38166994)
30. Pedersen NL, Lichtenstein P, Svedberg P. 2002. The Swedish Twin Registry in the third millennium. Twin Res 5:427-432. (Pubitemid 35315496)
31. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699.
32. Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, Brookes AJ. 2001. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 11:152-162. (Pubitemid 32117961)
33. Prince JA, Zetterberg H, Andreasen N, Marcusson J, Blennow K. 2004. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62:2116-2118. (Pubitemid 38738236)
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575. (Pubitemid 47330214)
35. Rodríguez-Rodríguez E, Mateo I, Llorca J, Sánchez-Quintana C, Infante J, García- Gorostiaga I, Sánchez-Juan P, Berciano J, Combarros O. 2007. Association of genetic variants of ABCA1 with Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet 144B:964-968. (Pubitemid 47548001)
36. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, George-Hyslop PHS. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
37. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-355. (Pubitemid 29369525)
38. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870. (Pubitemid 26296755)
39. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
40. Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E. 2006. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 391:142-146. (Pubitemid 41736188)
41. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464. (Pubitemid 28249035)
42. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD. 1994. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 91:11183-11186. (Pubitemid 24985076)
43. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981. (Pubitemid 23069980)
44. Sundar PD, Feingold E, Minster RL, DeKosky ST, Kamboh MI. 2007. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging 28:856-862. (Pubitemid 46589738)
45. Tregouet DA, Ricard S, Nicaud V, Arnould I, Soubigou S, Rosier M, Duverger N, Poirier O, Mace S, Kee F, Morrison C, Denefle P, Tiret L, Evans A, Deleuze JF, Cambien F. 2004. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 24:775-781. (Pubitemid 38451619)
46. Vanmechelen E, Vanderstichele H. 1998. Towards an earlier diagnosis of Alzheimer's disease. J Biotechnol 66:229-231.
47. Viiri LE, Loimaala A, Nenonen A, Islam S, Vuori I, Karhunen PJ, Lehtimaki T. 2005. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 179:161-167. (Pubitemid 40249799)
48. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM. 2004. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279:40987-40993. (Pubitemid 39287699)
49. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161-169. (Pubitemid 351171403)
50. Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. 2003. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 24:421-426. (Pubitemid 36205049)
51. Yancey PG, Bortnick AE, Kellner-Weibel G, de la Llera-Moya M, Phillips MC, Rothblat GH. 2003. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23:712-719. (Pubitemid 36566157)
52. Yue P, Isley WL, Harris WS, Rosipal S, Akin CD, Schonfeld G. 2005. Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL. Atherosclerosis 178:107-113. (Pubitemid 39600822)